Furqan receives NCI leadership award

Muhammad Furqan, MD, associate professor in Hematology, Oncology, and Blood & Marrow Transplantation and leader of the Thoracic Multidisciplinary Oncology Group at the Holden Comprehensive Cancer Center (HCCC), has received a 2020 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute. This two-year, $119,982 award recognizes Furqan’s passion, advocacy, and hard work […]

Garje aims at GU cancers on multiple fronts

Genitourinary (GU) cancers, including prostate cancer, are the most common among men, and Rohan Garje, MBBS, clinical assistant professor in the Division of Hematology, Oncology, and Marrow Transplantation, has made them his singular focus. With two publications in the last month and multiple projects underway, the former fellow and recent addition to the faculty is […]

Phadke leads pilot study into “chemo brain”

Sneha Phadke, DO, assistant clinical professor in Hematology, Oncology and Blood & Marrow Transplantation and a breast medical oncologist at the Holden Comprehensive Cancer Center (HCCC), is investigating the cognitive deficits that occur following chemotherapy, which has often been called “chemo brain.” Last month, Phadke and associate research scientist Kanchna Ramchandran, MS, PhD, were awarded […]

Liquid biopsy reveals ability to tailor treatment

Cholangiocarcinoma (CCA) is a cancer that arises from bile ducts/channels draining bile in the liver and often includes the gallbladder cancers. CCA is the second most common form of cancerous liver lesions. In 2017, Linda Kilcrease came to Pashtoon Kasi, MD, MS (then at Mayo Clinic), with metastatic cancer, but it was not amenable or […]

Iowa results part of NEJM publication

A recent issue of the New England Journal of Medicine features the results of a multi-site clinical trial in which Dr. Mo Milhem and the University of Iowa’s Holden Comprehensive Cancer Center participated. Sorafenib, a kinase inhibitor primarily used to treat renal, hepatic, and thyroid carcinomas, was used against a placebo in a double-blind, phase […]

Talking It Through

For 90 minutes every other week, about a dozen people share a small, comfortable space and talk about their cancer. They talk about how it felt to learn of their diagnosis, they talk about wrangling with insurance companies, they talk about the next round of treatment, they talk about their fear that remission may end. […]

Cancer Center Designated “High Performing Site”

Last year, the Holden Comprehensive Cancer Center (HCCC) at the University of Iowa received its third renewal of its designation as “Comprehensive,” a label that brings with it a great deal of support from the National Institutes of Health’s National Cancer Institute (NCI). This designation recognizes the breadth, leadership, depth, and rigor of the HCCC’s […]